Neurobiological Technologies is a biopharmaceutical company that develops proprietary therapeutic products based on advances in neuroscience research. The company has several products in various stages of development and testing. Its corticotropin-releasing factor (CRF) is designed to treat asthma, rheumatoid arthritis, and swelling caused by brain tumors. Its memantine is a potential neuroprotective agent that could treat neurodegenerative diseases such as AIDS-related dementia complex. Its dynorphin A and Nicosim products are being evaluated for use as analgesics for patients with severe chronic pain. NTII has 3 products in development: Corticotropin, an anti-inflammatory drug; Dynorphin A, a reducer of morphine dependence; and Nicosim, an aid to stop nicotine addiction.
-- hoovers description
Anyone know this company? |
